Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to -$522000.0.

  • Dna X's Interest & Investment Income changed N/A to -$522000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 365555.56%. This contributed to the annual value of -$29000.0 for FY2024, which is 9333.33% down from last year.
  • Per Dna X's latest filing, its Interest & Investment Income stood at -$522000.0 for Q3 2025.
  • Dna X's Interest & Investment Income's 5-year high stood at -$1000.0 during Q4 2022, with a 5-year trough of -$522000.0 in Q3 2025.
  • Its 4-year average for Interest & Investment Income is -$95250.0, with a median of -$19500.0 in 2022.
  • As far as peak fluctuations go, Dna X's Interest & Investment Income soared by 8571.43% in 2023, and later crashed by 218823.53% in 2025.
  • Dna X's Interest & Investment Income (Quarter) stood at -$1000.0 in 2022, then crashed by 300.0% to -$4000.0 in 2023, then tumbled by 200.0% to -$12000.0 in 2024, then plummeted by 4250.0% to -$522000.0 in 2025.
  • Its Interest & Investment Income stands at -$522000.0 for Q3 2025, versus -$389000.0 for Q2 2025 and -$91000.0 for Q1 2025.